TONYA DENNISON: Open Payments
NPI 1699967463 · PEKIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 26 payments from 15 companies in 2025. Trend: 2023 $174 · 2024 $338 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| ABBVIE INC. | 3 | $69 |
| Amgen Inc. | 3 | $58 |
| Astellas Pharma US Inc | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $49 |
| Novo Nordisk Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: Veozah, REXULTI, Cologuard Collection Kit, LEQVIO, UBRELVY, EVENITY, ENTRESTO, QULIPTA.
Industry payments across IL — which companies pay providers there.
